{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:11:05Z","timestamp":1773306665449,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["HL076675"],"award-info":[{"award-number":["HL076675"]}]},{"name":"National Institute of Health","award":["HL52141"],"award-info":[{"award-number":["HL52141"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.yjmcc.2011.08.025","type":"journal-article","created":{"date-parts":[[2011,9,3]],"date-time":"2011-09-03T08:02:40Z","timestamp":1315036960000},"page":"980-987","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacological inhibition of \u03b2IIPKC is cardioprotective in late-stage hypertrophy"],"prefix":"10.1016","volume":"51","author":[{"given":"Julio C.B.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh S.","family":"Palaniyandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric N.","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Budas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Helene","family":"Disatnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia C.","family":"Brum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Mochly-Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2011.08.025_bb0005","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1161\/CIRCULATIONAHA.105.171600","article-title":"Heart disease and stroke statistics\u20142006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"113","author":"Thom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.CIR.99.3.384","article-title":"Increased protein kinase C activity and expression of Ca2+\u2212sensitive isoforms in the failing human heart","volume":"99","author":"Bowling","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11010-007-9533-3","article-title":"Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy","volume":"305","author":"Simonis","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1006\/jmcc.2002.2089","article-title":"Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta","volume":"34","author":"Inagaki","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0025","doi-asserted-by":"crossref","first-page":"29644","DOI":"10.1074\/jbc.M101044200","article-title":"Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C","volume":"276","author":"Stebbins","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nbt1098-919","article-title":"Peptide modulators of protein\u2013protein interactions in intracellular signaling","volume":"16","author":"Souroujon","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.pharmtox.48.121806.154902","article-title":"PKC isozymes in chronic cardiac disease: possible therapeutic targets?","volume":"48","author":"Churchill","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0040","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1074-5521(01)00076-X","article-title":"Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7)","volume":"8","author":"Chen","year":"2001","journal-title":"Chem Biol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0050","first-page":"173","article-title":"Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood\u2013brain barrier breakdown in rats","volume":"118","author":"Qi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.yjmcc.2008.08.009","article-title":"Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure","volume":"45","author":"Palaniyandi","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0008-6363(97)00278-2","article-title":"Early changes in excitation\u2013contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes","volume":"37","author":"Nagata","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0091-679X(03)72018-4","article-title":"Ratio imaging: measuring intracellular Ca++ and pH in living cells","volume":"72","author":"Silver","year":"2003","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvp334","article-title":"Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion","volume":"85","author":"Churchill","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0075","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/01.CIR.98.19.2065","article-title":"Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats","volume":"98","author":"Iwanaga","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1291\/hypres.26.643","article-title":"Impaired Ca2+ handling in perfused hypertrophic hearts from Dahl salt-sensitive rats","volume":"26","author":"Seki","year":"2003","journal-title":"Hypertens Res Clin Experiment"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0085","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1006\/jmcc.2000.1206","article-title":"Abnormalities of calcium cycling in the hypertrophied and failing heart","volume":"32","author":"Houser","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pharmthera.2004.10.006","article-title":"Gene therapy targeted at calcium handling as an approach to the treatment of heart failure","volume":"105","author":"Hoshijima","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yjmcc.2008.05.011","article-title":"Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure","volume":"45","author":"Bartholomeu","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yjmcc.2004.10.014","article-title":"A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C","volume":"38","author":"Kobayashi","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0105","doi-asserted-by":"crossref","first-page":"24135","DOI":"10.1074\/jbc.M413015200","article-title":"Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation","volume":"280","author":"Itoh","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.lfs.2011.01.009","article-title":"Angiotensin receptor blockade improves the net balance of cardiac Ca(2+) handling-related proteins in sympathetic hyperactivity-induced heart failure","volume":"88","author":"Ferreira","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0115","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00421-008-0967-4","article-title":"Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice","volume":"105","author":"Pereira","year":"2009","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0120","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.RES.80.5.720","article-title":"C2 region-derived peptides of beta-protein kinase C regulate cardiac Ca2+ channels","volume":"80","author":"Zhang","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardiores.2004.12.022","article-title":"Regulation of cardiac contractile function by troponin I phosphorylation","volume":"66","author":"Layland","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.yjmcc.2006.08.016","article-title":"PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144","volume":"41","author":"Wang","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00059-002-2354-y","article-title":"Cardiac fibrosis as a cause of diastolic dysfunction","volume":"27","author":"Burlew","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00001573-200111000-00003","article-title":"Clinical aspects of hypertensive myocardial fibrosis","volume":"16","author":"Diez","year":"2001","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0145","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/HJH.0b013e3283316c4d","article-title":"Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure","volume":"27","author":"Plaksej","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0150","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvp001","article-title":"Protein kinase C in heart failure: a therapeutic target?","volume":"82","author":"Palaniyandi","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0160","first-page":"H2264","article-title":"PKC-beta is not necessary for cardiac hypertrophy","volume":"280","author":"Roman","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0165","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1073\/pnas.94.17.9320","article-title":"Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy","volume":"94","author":"Wakasaki","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0170","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1172\/JCI119755","article-title":"Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates","volume":"100","author":"Bowman","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0175","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/db06-0655","article-title":"Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats","volume":"56","author":"Arikawa","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.108.765750","article-title":"Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy","volume":"2","author":"Connelly","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0185","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.105.592550","article-title":"Pharmacological- and gene therapy-based inhibition of protein kinase Calpha\/beta enhances cardiac contractility and attenuates heart failure","volume":"114","author":"Hambleton","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0190","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1582-4934.2010.01174.x","article-title":"PKCbetaII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses","volume":"15","author":"Palaniyandi","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0195","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.RES.0000105087.79373.17","article-title":"Protein kinase Calpha negatively regulates systolic and diastolic function in pathological hypertrophy","volume":"93","author":"Hahn","year":"2003","journal-title":"Circ Res"},{"issue":"Pt 2","key":"10.1016\/j.yjmcc.2011.08.025_bb0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/bj2940335","article-title":"Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C","volume":"294","author":"Wilkinson","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.yjmcc.2011.08.025_bb0205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/hc3101.092201","article-title":"Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure","volume":"104","author":"Iwanaga","year":"2001","journal-title":"Circulation"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811003725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811003725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T03:50:38Z","timestamp":1543549838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282811003725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0022282811003725"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2011.08.025","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}